Weekly Research Analysts’ Ratings Updates for HCA Healthcare (HCA)

04 Nov 2025, 10:58 by Jessica Moore · The Cerbat Gem

Several analysts have recently updated their ratings and price targets for HCA Healthcare (NYSE: HCA):

10/29/2025 – HCA Healthcare was upgraded by analysts at Zacks Research from a “hold” rating to a “strong-buy” rating.
10/28/2025 – HCA Healthcare had its price target raised by analysts at Jefferies Financial Group Inc. from $485.00 to $525.00. They now have a “buy” rating on the stock.
10/27/2025 – HCA Healthcare had its “buy” rating reaffirmed by analysts at Cowen Inc.
10/27/2025 – HCA Healthcare had its price target raised by analysts at Barclays PLC from $445.00 to $494.00. They now have an “overweight” rating on the stock.
10/27/2025 – HCA Healthcare had its price target raised by analysts at UBS Group AG from $495.00 to $525.00. They now have a “buy” rating on the stock.
10/27/2025 – HCA Healthcare was given a new $425.00 price target on by analysts at Morgan Stanley.
10/27/2025 – HCA Healthcare had its price target raised by analysts at The Goldman Sachs Group, Inc. from $470.00 to $520.00. They now have a “buy” rating on the stock.
10/27/2025 – HCA Healthcare was given a new $525.00 price target on by analysts at Raymond James Financial, Inc..
10/27/2025 – HCA Healthcare had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald.
10/27/2025 – HCA Healthcare had its “market perform” rating reaffirmed by analysts at Sanford C. Bernstein. They now have a $417.00 price target on the stock.
10/27/2025 – HCA Healthcare had its price target raised by analysts at Bank of America Corporation from $430.00 to $470.00. They now have a “neutral” rating on the stock.
10/27/2025 – HCA Healthcare had its price target raised by analysts at TD Cowen from $380.00 to $490.00. They now have a “buy” rating on the stock.
10/27/2025 – HCA Healthcare had its price target raised by analysts at Royal Bank Of Canada from $449.00 to $482.00. They now have an “outperform” rating on the stock.
10/27/2025 – HCA Healthcare had its price target raised by analysts at Stephens from $450.00 to $500.00. They now have an “overweight” rating on the stock.
10/27/2025 – HCA Healthcare had its price target raised by analysts at Truist Financial Corporation from $460.00 to $495.00. They now have a “buy” rating on the stock.
10/27/2025 – HCA Healthcare had its price target raised by analysts at Mizuho from $475.00 to $505.00. They now have an “outperform” rating on the stock.
10/27/2025 – HCA Healthcare had its price target raised by analysts at Oppenheimer Holdings, Inc. from $400.00 to $500.00. They now have an “outperform” rating on the stock.
10/27/2025 – HCA Healthcare had its price target raised by analysts at KeyCorp from $465.00 to $475.00. They now have an “overweight” rating on the stock.
10/25/2025 – HCA Healthcare was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating.
10/17/2025 – HCA Healthcare had its price target raised by analysts at Mizuho from $425.00 to $475.00. They now have an “outperform” rating on the stock.
10/15/2025 – HCA Healthcare had its price target raised by analysts at Jefferies Financial Group Inc. from $400.00 to $485.00.
10/14/2025 – HCA Healthcare was given a new $460.00 price target on by analysts at Truist Financial Corporation.
10/14/2025 – HCA Healthcare had its price target raised by analysts at UBS Group AG from $438.00 to $495.00. They now have a “buy” rating on the stock.
10/14/2025 – HCA Healthcare is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $470.00 price target on the stock.
10/14/2025 – HCA Healthcare is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $470.00 price target on the stock.
10/8/2025 – HCA Healthcare had its price target raised by analysts at KeyCorp from $370.00 to $465.00. They now have an “overweight” rating on the stock.
10/8/2025 – HCA Healthcare was given a new $465.00 price target on by analysts at UBS Group AG.
10/8/2025 – HCA Healthcare had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
10/7/2025 – HCA Healthcare had its price target raised by analysts at Wells Fargo & Company from $375.00 to $412.00. They now have an “equal weight” rating on the stock.
10/7/2025 – HCA Healthcare had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $444.00 price target on the stock.
9/27/2025 – HCA Healthcare had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
9/18/2025 – HCA Healthcare had its price target raised by analysts at Barclays PLC from $390.00 to $445.00. They now have an “overweight” rating on the stock.
9/10/2025 – HCA Healthcare had its price target raised by analysts at Bank of America Corporation from $375.00 to $410.00. They now have a “neutral” rating on the stock.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be given a dividend of $0.72 per share. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s payout ratio is currently 11.13%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Weekly Research Analysts’ Ratings Updates for HCA Healthcare (HCA)

HCA Healthcare Dividend Announcement

Insider Buying and Selling at HCA Healthcare

Read More